About this Event
Delivered in partnership with ARCS Australia as part of the ARCS Annual Conference, Biobeacon - the NSW Drug Discovery Forum platforms the latest therapeutic ideas from researchers across the state to a panel of industry experts for live feedback.
Join us on 11 June and discover how the latest commercialisation pathways and pharmaceutical industry trends apply to groundbreaking pre-IP research being conducted in NSW currently.
This full-day event features catered networking intervals and pitch sessions focusing on oncology, CNS and neurological disorders, cardiometabolic diseases, inflammation, and infectious diseases. Connect with researchers, investment and industry professionals.
General registration is free to researchers based in medical institutes and universities, and government. Please note places are limited. Industry attendees are invited to register via the ARCS Annual Conference portal ($170 per person).
The NSW Drug Discovery Forum is proudly supported by the Office of the NSW Chief Scientist & Engineer and coordinated by the Centre for Drug Discovery Innovation and ARCS Australia. Sponsored by ABINITIO, Therapeutic Innovation Australia, FPA Patent Attorneys, AusBiotech, Biointelect Pty Ltd, MedChem Australia, MedChemExpress LLC, John Morris Group and TargetMol Chemicals Inc.
Learn more about the NSW Drug Discovery Forum 2026
Event Venue & Nearby Stays
ICC Sydney, 14 Darling Drive, Sydney, Australia
AUD 0.00
